Comparison of short- and long-acting benzodiazepine-receptor agonists with different receptor selectivity on motor coordination and muscle relaxation following thiopental-induced anesthesia in mice.

In this study, we compared the effects of Type I benzodiazepine receptor-selective agonists (zolpidem, quazepam) and Type I/II non-selective agonists (zopiclone, triazolam, nitrazepam) with either an ultra-short action (zolpidem, zopiclone, triazolam) or long action (quazepam, nitrazepam) on motor coordination (rota-rod test) and muscle relaxation (traction test) following the recovery from thiopental-induced anesthesia (20 mg/kg) in ddY mice. Zolpidem (3 mg/kg), zopiclone (6 mg/kg), and triazolam (0.3 mg/kg) similarly caused an approximately 2-fold prolongation of the thiopental-induced anesthesia. Nitrazepam (1 mg/kg) and quazepam (3 mg/kg) showed a 6- or 10-fold prolongation of the anesthesia, respectively. Zolpidem and zopiclone had no effect on the rota-rod and traction test. Moreover, zolpidem did not affect motor coordination and caused no muscle relaxation following the recovery from the thiopental-induced anesthesia. However, zopiclone significantly impaired the motor coordination at the beginning of the recovery. Triazolam significantly impaired the motor coordination and muscle relaxant activity by itself, and these impairments were markedly exacerbated after the recovery from anesthesia. Nitrazepam and quazepam significantly impaired motor coordination, and the impairments were exacerbated after the recovery. These results suggest that the profile of recovery of motor coordination and muscle flaccidity after co-administration of benzodiazepine-receptor agonists and thiopental is related to the half-life and selectivity for the benzodiazepine-receptor subtypes.

[1]  S. Budhiraja,et al.  Adjuvant effect of melatonin on anesthesia induced by thiopental sodium, ketamine, and ether in rats. , 2005, Methods and findings in experimental and clinical pharmacology.

[2]  P. Gagnon,et al.  Association between psychoactive medications and delirium in hospitalized patients: a critical review. , 2005, Psychosomatics.

[3]  K. Abe,et al.  [Pharmacological profiles of benzodiazepinergic hypnotics and correlations with receptor subtypes]. , 2005, Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology.

[4]  H. Salahdeen,et al.  Neurosedative and muscle relaxant activities of aqueous extract of Bryophyllum pinnatum. , 2005, Fitoterapia.

[5]  P. J. Bowman,et al.  Central Nervous System–Active Medications and Risk for Falls in Older Women , 2002, Journal of the American Geriatrics Society.

[6]  Chunrong Ma,et al.  Discriminative stimulus effects of benzodiazepine (BZ)(1) receptor-selective ligands in rhesus monkeys. , 2002, The Journal of pharmacology and experimental therapeutics.

[7]  J. Avorn,et al.  Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. , 2001, The American journal of psychiatry.

[8]  S. Volpato,et al.  Benzodiazepines with different half-life and falling in a hospitalized population: The GIFA study. Gruppo Italiano di Farmacovigilanza nell'Anziano. , 2000, Journal of clinical epidemiology.

[9]  W. Ray,et al.  Benzodiazepines and the Risk of Falls in Nursing Home Residents , 2000, Journal of the American Geriatrics Society.

[10]  R. Mckernan,et al.  Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype , 2000, Nature Neuroscience.

[11]  C. Belzung,et al.  Naloxone potentiates anxiolytic-like actions of diazepam, pentobarbital and meprobamate but not those of Ro19-8022 in the rat. , 2000, European journal of pharmacology.

[12]  J. Benson,et al.  Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes , 1999, Nature.

[13]  G. Perrault,et al.  Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligands. , 1999, Behavioural pharmacology.

[14]  M. Ticku,et al.  An update on GABAA receptors , 1999, Brain Research Reviews.

[15]  M. Tinetti,et al.  Drugs and Falls in Older People: A Systematic Review and Meta‐analysis: I. Psychotropic Drugs , 1999, Journal of the American Geriatrics Society.

[16]  A. Forster,et al.  Patient Evaluation and Comparison of the Recovery Profile between Propofol and Thiopentone as Induction Agents in Day Surgery , 1998, Anaesthesia and intensive care.

[17]  W. Wisden,et al.  GABA(A)-receptor subtypes: clinical efficacy and selectivity of benzodiazepine site ligands. , 1997, Annals of medicine.

[18]  G. Perrault,et al.  The mouse defense test battery: evaluation of the effects of non-selective and BZ-1 (omega1) selective, benzodiazepine receptor ligands. , 1996, Behavioural pharmacology.

[19]  S. Bohlhalter,et al.  Laminar compartmentalization of GABAA-receptor subtypes in the spinal cord: an immunohistochemical study , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  J. Bénavidès,et al.  Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system. , 1992, The Journal of pharmacology and experimental therapeutics.

[21]  J. Calleja,et al.  Effects of Skeletonema costatum Extracts on the Central Nervous System , 1992, Planta medica.

[22]  P. Benfield,et al.  Zolpidem , 1990, Drugs.

[23]  R. Griffiths,et al.  Relative Abuse Liability of Different Benzodiazepines in: Drug Abusers , 1990, Journal of clinical psychopharmacology.

[24]  J. Bénavidès,et al.  Distribution of central omega 1 (benzodiazepine1) and omega 2 (benzodiazepine2) receptor subtypes in the monkey and human brain. An autoradiographic study with [3H]flunitrazepam and the omega 1 selective ligand [3H]zolpidem. , 1988, The Journal of pharmacology and experimental therapeutics.

[25]  M. S. Langley,et al.  Brotizolam , 1988, Drugs.

[26]  B. Scatton,et al.  Autoradiographic Localization of [3H]Zolpidem Binding Sites in the Rat CNS: Comparison with the Distribution of [3H]Flunitrazepam Binding Sites , 1987, Journal of neurochemistry.

[27]  L. Newman,et al.  Effects of Chronic Alcohol Intake on Anesthetic Responses to Diazepam and Thiopental in Rats , 1986, Anesthesiology.

[28]  Y. Ichimaru,et al.  [Behavioral and electroencephalographic study of 7-chloro-1-methyl-5-phenyl-1 H-1,5-benzodiazepine-2,4-(3H,5H)-dione (clobazam)]. , 1983, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[29]  P. Saab,et al.  The effects of flurazepam, lorazepam, and triazolam on sleep and memory , 1980, Psychopharmacology.

[30]  W. Sieghart Structure, pharmacology, and function of GABAA receptor subtypes. , 2006, Advances in pharmacology.

[31]  J. Benson,et al.  Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. , 1999, Nature.

[32]  A. Zharkovsky,et al.  The Effects of Drugs Acting at GABA-Benzodiazepine-Barbiturate Receptor Complex on the Behaviour of Sleep-Deprived Mice , 1995 .

[33]  L. Firestone GENERAL ANESTHETICS , 1988, International anesthesiology clinics.

[34]  裕 五味田,et al.  7-Chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4-(3H,5H:)-dione(Clobazam)の行動薬理学的ならびに脳波学的研究 , 1983 .

[35]  D. Roberts,et al.  The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod. , 1968, The Journal of pharmacy and pharmacology.